| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?
|
Sanchis-Gomar, Fabian
|
|
|
20 |
5 |
p. 413-418
|
artikel
|
| 2 |
Author’s Reply to Peverill: “Predictors of Left Ventricular Dysfunction in Friedreich’s Ataxia in a 16-Year Observational Study”
|
Pousset, Francoise
|
|
|
20 |
5 |
p. 511
|
artikel
|
| 3 |
Author’s Reply to Vaz et al.: “Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Liver Disease”
|
Fu, Yonghui
|
|
|
20 |
5 |
p. 507-508
|
artikel
|
| 4 |
Comment on: Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Liver Disease
|
Vaz, Igor
|
|
|
20 |
5 |
p. 505
|
artikel
|
| 5 |
Comment on: “Predictors of Left Ventricular Dysfunction in Friedreich Ataxia in a 16-Year Observational Study”
|
Peverill, Roger E.
|
|
|
20 |
5 |
p. 509-510
|
artikel
|
| 6 |
Current Overview on Hypercoagulability in COVID-19
|
Singhania, Namrata
|
|
|
20 |
5 |
p. 393-403
|
artikel
|
| 7 |
Effectiveness and Safety of Restarting Oral Anticoagulation in Patients with Atrial Fibrillation after an Intracranial Hemorrhage: Analysis of Medicare Part D Claims Data from 2010–2016
|
Newman, Terri V.
|
|
|
20 |
5 |
p. 471-479
|
artikel
|
| 8 |
Effects of Blood Pressure Lowering Agents on Cardiovascular Outcomes in Weight Excess Patients: A Systematic Review and Meta-analysis
|
Francischetti, Emilio Antonio
|
|
|
20 |
5 |
p. 447-470
|
artikel
|
| 9 |
Evolution of Patients with Pulmonary Arterial Hypertension Starting Macitentan After the Discontinuation of Other Endothelin-Receptor Antagonists: Results of a Retrospective Study
|
Cadenas-Menéndez, Sergio
|
|
|
20 |
5 |
p. 481-487
|
artikel
|
| 10 |
Pharmacologic Management of Gout in Patients with Cardiovascular Disease and Heart Failure
|
Mouradjian, Mallory T.
|
|
|
20 |
5 |
p. 431-445
|
artikel
|
| 11 |
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alirocumab in Healthy Chinese Subjects: A Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study
|
Li, Haiyan
|
|
|
20 |
5 |
p. 489-503
|
artikel
|
| 12 |
Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors for Cardiovascular Disease Prevention
|
Reid, Jessica
|
|
|
20 |
5 |
p. 419-429
|
artikel
|
| 13 |
Statins, LDL Cholesterol Control, Cardiovascular Disease Prevention, and Atherosclerosis Progression: A Clinical Perspective
|
Nesti, Lorenzo
|
|
|
20 |
5 |
p. 405-412
|
artikel
|
Tijdschrift beschrijving